Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
EPS for Intersect ENT (XENT)
EPS in 2020: -$2.22
According to Intersect ENT's latest financial reports the company's current EPS (TTM) is -$2.22. In 2020 the company made an earnings per share (EPS) of -$2.22 a decrease over its 2019 EPS that were of -$1.37.
EPS history for Intersect ENT from 2012 to 2020
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2020 | -$2.22 | 62.04% |
| 2019 | -$1.37 | 80.26% |
| 2018 | -$0.76 | 35.71% |
| 2017 | -$0.56 | -37.08% |
| 2016 | -$0.89 | -12.75% |
| 2015 | -$1.02 | -36.65% |
| 2014 | -$1.61 | 37.61% |
| 2013 | -$1.17 | 24.93% |
| 2012 | -$0.94 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | -$1.16 | -47.75% | 🇺🇸 USA |
 ICON plc ICLR | $6.27 | -382.43% | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | -$1.53 | -31.08% | 🇺🇸 USA |
 Haemonetics HAE | $2.53 | -214.12% | 🇺🇸 USA |